ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,585.60
      -0.15%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      83.755
      0.23%
      Bitcoin
      61,648.73
      0.75%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. KalVista Pharmaceuticals Inc (KALV)

      7. KalVista Pharmaceuticals Inc (KALV) News

      KALV KalVista Pharmaceuticals Inc

      12.06
      -0.13 (-1.07%)
      May 08 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      KalVista Pharmaceuticals Inc KALV NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.13 -1.07% 12.06 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      12.07 11.90 12.25 12.06 12.19
      more quote information »

      Recent News

      Date Time Source Heading
      5/08/20249:05IHNWFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      5/02/202406:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
      5/01/202406:30BWKalVista Pharmaceuticals Highlights Strategic Plans for..
      4/22/202406:30BWKalVista Pharmaceuticals Appoints William C. Fairey to Board..
      4/03/202406:30BWKalVista Pharmaceuticals to Present at 23rd Annual Needham..
      4/02/202406:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
      3/18/202406:30BWKalVista Pharmaceuticals Presents Real-World Data on Burden..
      3/12/202406:30BWKalVista Pharmaceuticals Awarded UK Promising Innovative..
      3/11/202416:37EDGAR2Form 8-K - Current report
      3/11/202416:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      3/11/202406:30BWKalVista Pharmaceuticals Reports Third Fiscal Quarter..
      3/08/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202406:30BWKalVista Pharmaceuticals to Present HAE Attack Journey Data..
      3/07/202406:38EDGAR2Form 8-K - Current report
      3/07/202406:30BWKalVista Pharmaceuticals Announces Appointment of Benjamin..
      3/06/202406:30BWKalVista Pharmaceuticals to Participate in the Leerink..
      3/04/202406:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
      2/27/202406:30BWKalVista Pharmaceuticals Presents Data on Unmet Needs in HAE..
      2/26/202406:30BWKalVista Pharmaceuticals Presents Additional Phase 3..
      2/22/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/22/202413:22EDGAR2Form SC 13D/A - General statement of acquisition of..
      2/21/202421:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/21/202421:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202416:49EDGAR2Form SC 13D/A - General statement of acquisition of..
      2/20/202406:30BWKalVista Pharmaceuticals Awarded UK Innovation Passport for..
      2/16/202416:32EDGAR2Form 8-K - Current report
      2/16/202416:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      2/16/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202406:30BWKalVista Pharmaceuticals to Present Phase 3 Sebetralstat..
      2/15/202406:30BWKalVista Pharmaceuticals Announces Pricing of a $160.1..
      2/14/202420:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202417:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      2/14/202416:18BWKalVista Pharmaceuticals Announces Proposed Public Offering..
      2/14/202416:14EDGAR2Form 8-K - Current report
      2/13/202409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202409:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202409:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202409:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/13/202406:55EDGAR2Form 8-K - Current report
      2/13/202406:30BWKalVista Pharmaceuticals Reports Phase 3 KONFIDENT Trial..
      2/12/202420:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/08/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/05/202417:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202406:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..

      Your Recent History

      NASDAQ
      KALV
      KalVista Pharmaceuticals
      Delayed Upgrade Clock